Detalhe da pesquisa
1.
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS.
Blood
; 143(3): 258-271, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879074
2.
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma.
Blood
; 139(26): 3708-3721, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090171
3.
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia.
Mol Ther
; 29(4): 1529-1540, 2021 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388419
4.
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.
Cancer Immunol Res
; 11(9): 1222-1236, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37378662
5.
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.
J Clin Oncol
; 41(36): 5569-5578, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751561
6.
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials.
JAMA Oncol
; 8(10): 1456-1465, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006624
7.
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity.
Leukemia
; 36(6): 1635-1645, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440691
8.
Rapidly Evolving Treatment Landscape for Metastatic Esophagogastric Carcinoma: Review of Recent Data.
Onco Targets Ther
; 14: 4361-4381, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34385820
9.
Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity.
Cancer Immunol Res
; 9(9): 1035-1046, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244299